Transcutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms and its impact on health-related quality of life in patients with parkinson disease: A randomized controlled trial

Journal of Wound, Ostomy and Continence Nursing

Volumn 42, Issue 1, 2015, Pages 94-99

  Perissinotto, Maria Carolina ^a   D'ancona, Carlos Arturo Levi ^a   Lucio, Adélia ^a   Campos, Renata Martins ^a   Abreu, Anelyssa ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

lower urinary tract symptoms; neurogenic bladder; Parkinson disease; transcutaneous tibial nerve stimulation

Indexed keywords

AGED; COMPLICATION; CONTROLLED STUDY; FEMALE; HUMAN; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; MORTALITY; PARKINSON DISEASE; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TIBIAL NERVE; TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION; TREATMENT OUTCOME; URINARY INCONTINENCE; URINARY INCONTINENCE, URGE;

AGED; FEMALE; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TIBIAL NERVE; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME; URINARY INCONTINENCE; URINARY INCONTINENCE, URGE;

EID: 84920658344     PISSN: 10715754     EISSN: None     Source Type: Journal    
DOI: 10.1097/WON.0000000000000078     Document Type: Article

References (23)

1. Campeau L, Soler R, Anderson KE. Bladder dysfunction and parkinsonism: current pathophysiological understanding and management strategies. Curr Urol Rep. 2011; 12: 396-403.
2. Yeo L, Singh R, Gundeti M, et al. Urinary tract dysfunction in Parkinson's disease: a review. Int Urol Nephrol. 2012; 44: 415-424.
3. Araki I, Kitahara M, Oida T, et al. Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms. J Urol. 2000; 164: 1640-1643.
4. Sammour ZM, Gomes CM, Barbosa ER, et al. Voiding dysfunction in patients with Parkinson's disease: impact of neurological impairment and clinical parameters. Neurourol Urodyn. 2009; 28: 510-515.
5. Madhuvrata P, Cody JD, Ellis G, et al. Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev. 2012; 18: 1.
6. Basra RK, Wagg A, Chapple C, et al. A review of adherence to drug therapy in patients with overactive bladder. BJU Int. 2008; 102: 774-779.
7. Chancellor MB, Anderson RU, Boone TB. Pharmacotherapy for neurogenic detrusor overactivity. Am J Phys Med Rehabil. 2006; 85: 536-545.
8. Stöhrer M, Blok B, Castro-Diaz D, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009; 56: 81-88.
9. Kabay SC, Yucel M, Kabay S. Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study. Urology. 2008; 71 (4): 641-645.
10. McClurg D, Ashe RG, Marshall K, et al. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn. 2006; 25: 337-348.
11. Kabay SC, Kabay S, Yucel M, et al. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease. Neurourol Urodyn. 2009; 28: 62-67.
12. Lúcio AC, Campos RM, Perissinotto MC, et al. Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis. Neurourol Urodyn. 2010; 29: 1410-1413.
13. Amarenco G, Ismael SS, Even-Schneider A, et al. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol. 2003; 169: 2210-2215.
14. Vaughan CP, Juncos JL, Burgio KL, et al. Behavioral therapy to treat urinary incontinence in Parkinson disease. Neurology. 2011; 76: 1631-1634.
15. Monga AK, Tracey MR, Subbaroyan J. A systematic review of clinical studies of electrical stimulation for treatment of lower urinary tract dysfunction. Int Urogynecol J. 2012; 23 (8): 993-1005.
16. Lúcio AC, Perissinotto MCR, D'Ancona CAL, et al. A comparative study of pelvic floor muscle training in women with multiple sclerosis: its impact on lower urinary tract symptoms and quality of life. Clinics. 2011; 66: 1563-1568.
17. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008; 23: 2129-2170.
18. Abrams P, Cardozo L, Fall M, et al. The standardization of terminology in lower urinary tract function: report from the standardization subcommittee of the International Continence Society. Urology. 2003; 61: 37-49.
19. Shafer W, Abrams P, Liao L, et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn. 2002; 21: 261-274.
20. Sèze M, Raibaut P, Gallien P, et al. Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn. 2011; 30: 306-311.
21. Acquadro C, Kopp Z, Coyne KS, et al. Translating overactive bladder questionnaires in 14 languages. Urology. 2006; 67: 536-540.
22. Tamanini JT, Dambros M, D'Ancona CA, et al. Validation of the "International Consultation on Incontinence Questionnaire- Short Form" (ICIQ-SF) for Portuguese. Rev Saúde Pública. 2004; 38: 438-444.
23. Blackett H, Walker R, Wood B. Urinary dysfunction in Parkinson's disease: a review. Park Relat Disord. 2009; 15: 81-87.